Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trialDerin B. Keskin, David A. Reardon|Nature|2018Cited by 1.4k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directionsPatrick Y. Wen, Martin J. van den Bent, Jonathan Tsang et al.|Neuro-Oncology|2020Cited by 1.1k
Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39Maisa C. Takenaka, Francisco J. Quintana, Galina Gabriely et al.|Nature Neuroscience|2019Cited by 528
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated <i>MGMT</i> promoterMichael Lim, Antonio Omuro, Michael Weller et al.|Neuro-Oncology|2022Cited by 508
Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent ModelDavid A. Reardon, Gordon J. Freeman|Cancer Immunology Research|2015Cited by 434